Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data Analysis

This paper, published in Clinical and Applied Thrombosis/Hemostasis, was researched and written by KMK team members Yulin Shi, Luyang He, and Ying Shen with co-authors Denise Clayton, Glorian Yen, Soyon Lee, Lincy Geevarghese, Jason Shafrin and Anem Waheed. Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematologic disorder commonly treated with complement inhibitors such as […]

Smarter Real World Evidence

A Flexible Client-Centered Dashboard Can Help Data Tell a Better Story If analyzed correctly, compelling data can serve business needs and reveal commercial opportunities. The KMK Real World Evidence Dashboard is a customized client-centered approach to help biopharmaceutical companies reach intuitive conclusions faster, save significant time on re-analysis, and improve recall and comprehension with a […]

HEOR & RWE: The Path to Effective Drug Development

HEOR & RWE: The Path to Effective Drug Development Since the FDA introduced the 21st Century Cures Act in 2016, pharmaceutical companies have recognized that regulatory approval alone does not determine a drug’s efficacy or even commercial success, compelling them to evaluate every product from a value standpoint. Consequently, today’s pharmaceutical sector relies heavily on […]